Description
KB-0742 dihydrochloride is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KB-0742 dihydrochloride is a selective CDK9 inhibitor with potent anti-tumor activity in castration-resistant prostate cancer models.
| Cas No. | 2416874-75-2 |
|---|---|
| Purity | ≥99% |
| Formula | C16H25N5 • 2HCl |
| Formula Wt. | 360.32 |
| IUPAC Name | (1S,3S)-3-N-(5-pentan-3-ylpyrazolo[1,5-a]pyrimidin-7-yl)cyclopentane-1,3-diamine dihydrochloride |
| Synonym | KB0742 dihydrochloride, NSC-834161 dihydrochloride, NSC834161 dihydrochloride |
| Appearance | Yellow crystal powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Richters A, Doyle S, Freeman D, et al. Modulating androgen receptor-driven transcription in prostate cancer with selective CDK9 inhibitors. Cell Chem Biol. 2021 Feb 18;28(2):134-147. PMID: 33086052
TRPV1 agonist, histamine H1 antagonist.
c-MET inhibitor.
Impurity of rapamycin
Ansamycin; bacterial DNA-dependent RNA polymera...
Resveratrol prodrug; potential SIRT1 activator....
STING inhibitor
Terpene lactone found in Ginkgo; GSK-3β inhibi...
Used to study embryonic cloning; microtubule po...
Curcumin derivative.
AMPK activator.
IGF-1R and InsR inhibitor.
DPP4 inhibitor.
Saponin found in Polygala.
Cysteine-ITC conjugate, antioxidant.
p110δ PI3K inhibitor.
RAF inhibitor.
5-HT3 antagonist.
PI3K and mTOR inhibitor.
Fluoroquinolone, S-(-) isomer of ofloxacin; top...
Mesalazine derivative, sulfa drug; sepiapterin ...